Annexin Pharmaceuticals AB (OSTO:ANNX) Total Debt per Share : kr0.00 (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Annexin Pharmaceuticals AB Total Debt per Share?

kr0.00 (As of Jun. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Annexin Pharmaceuticals AB's Total Debt Per Share for the quarter that ended in Jun. 2024 was kr0.00.

Annexin Pharmaceuticals AB Total Debt per Share Historical Data

The historical data trend for Annexin Pharmaceuticals AB's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annexin Pharmaceuticals AB Total Debt per Share Chart

Annexin Pharmaceuticals AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Debt per Share

Get a 7-Day Free Trial

Annexin Pharmaceuticals AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Debt per Share	Get a 7-Day Free Trial															-	0.04	-	-	-

Annexin Pharmaceuticals AB Total Debt per Share Calculation

Annexin Pharmaceuticals AB's Total Debt Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.00	+	0.00)	/	370.45
	=	0.00

Annexin Pharmaceuticals AB's Total Debt Per Share for the quarter that ended in Jun. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.00	+	0.00)	/	532.98
	=	0.00

Annexin Pharmaceuticals AB Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Annexin Pharmaceuticals AB's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Annexin Pharmaceuticals AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annexin Pharmaceuticals AB (OSTO:ANNX) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Norrtullsgatan 6, Stockholm, SWE, SE-113 29

Website

https://www.annexinpharma.com

Annexin Pharmaceuticals AB is a biotechnology company. It is developing biological drug candidate ANXV, a recombinant human protein Annexin A5 for treatment of various cardiovascular diseases. The company also focuses on development of ANXV for the treatment of retinal vein occlusion.